Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model.

OBJECTIVES To evaluate the histopathologic and computed tomography imaging features associated with irreversible electroporation (IRE) ablation performed in normal porcine kidneys. IRE is a nonthermal ablative tool that uses direct electrical pulses to create permanent "pores" in cell membranes and cell death. It does not affect the extracellular matrix. METHODS Fifteen female swine were treated with IRE using acute (<24 hours), subacute (36 hours), and chronic (3 weeks) treatment settings. Unipolar IRE applicators were placed under CT guidance. The renal pelvis/calyx was included in 18 ablations. Imaging and histopathologic follow-up were performed. RESULTS A total of 29 ablations (19 acute, 4 subacute, and 6 chronic) were created. Acute/subacute ablations showed complete cortical necrosis without intervening live cells. The pelvic epithelium was necrotic with urothelial sloughing; pelvic extracellular matrix was intact. Chronic ablations showed cortical fibrosis, regenerating renal pelvic epithelium and intact pelvic extracellular matrix. No thermal injury, renal pelvic, or blood vessel injury was seen. Immediate postprocedure CT imaging demonstrated a hypodense nonenhancing lesion that persisted at 1 week. Of the 6 chronic lesions, 4 showed complete resolution at 3 weeks on imaging. No collecting system damage was seen. CONCLUSIONS This preliminary porcine study demonstrates the nonthermal and connective tissue sparing mechanism of action of IRE. These features may protect against collecting system damage after IRE ablation of renal tissue. IRE could therefore play an important role in ablation of centrally located renal tumors.

[1]  J. J. de la Rosette,et al.  Follow‐up of renal masses after cryosurgery using computed tomography; enhancement patterns and cryolesion size , 2008, BJU international.

[2]  A. Crisci,et al.  Renal cryoablation and radio frequency ablation: an evaluation of worst case scenarios in a porcine model. , 2005, The Journal of urology.

[3]  A. Belldegrun,et al.  The effects of intentional cryoablation and radio frequency ablation of renal tissue involving the collecting system in a porcine model. , 2005, The Journal of urology.

[4]  Boris Rubinsky,et al.  In vivo results of a new focal tissue ablation technique: irreversible electroporation , 2006, IEEE Transactions on Biomedical Engineering.

[5]  R. Nelson,et al.  Complications after percutaneous radiofrequency ablation of renal tumors. , 2005, Urology.

[6]  Stephen T Kee,et al.  Imaging Guided Percutaneous Irreversible Electroporation: Ultrasound and Immunohistological Correlation , 2007, Technology in cancer research & treatment.

[7]  S. Mylona,et al.  Renal cell carcinoma radiofrequency ablation: evaluation of efficacy based on histological correlation. , 2008, The British journal of radiology.

[8]  R. Clayman,et al.  Laparoscopic cryoablation for small renal masses: three-year follow-up. , 2007, Urology.

[9]  S. Nakada,et al.  Magnetic resonance imaging findings after laparoscopic renal cryoablation. , 2006, Urology.

[10]  A. Oto,et al.  MR imaging of the kidneys after laparoscopic cryoablation. , 2000, AJR. American journal of roentgenology.

[11]  T. Gibson,et al.  Radiofrequency ablation for patients with colorectal cancer and unresectable liver metastasis. , 2006 .

[12]  Grant D. Taylor,et al.  The radiographic evolution of radio frequency ablated renal tumors. , 2004, The Journal of urology.

[13]  G. Sung,et al.  Effect of intentional cryo-injury to the renal collecting system. , 2003, The Journal of urology.

[14]  R. Uzzo,et al.  Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. , 2008, The Journal of urology.

[15]  Boris Rubinsky,et al.  The Effect of Irreversible Electroporation on Blood Vessels , 2007, Technology in cancer research & treatment.

[16]  Benjamin R. Lee,et al.  Optimal lesion assessment following acute radio frequency ablation of porcine kidney: cellular viability or histopathology? , 2003, The Journal of urology.

[17]  R. Stein,et al.  Renal cryotherapy: a detailed review including a 5‐year follow‐up , 2007, BJU international.

[18]  Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience. , 2007, Radiology.

[19]  R. Kalluri,et al.  Possible mechanisms of kidney repair , 2009, Fibrogenesis & tissue repair.

[20]  L. Kavoussi,et al.  Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup. , 2005, The Journal of urology.

[21]  A. Maeshima Label-retaining cells in the kidney: origin of regenerating cells after renal ischemia , 2007, Clinical and Experimental Nephrology.

[22]  D. Breen,et al.  Immediate and long-term CT appearances following radiofrequency ablation of renal tumours. , 2008, Clinical radiology.

[23]  L. Kavoussi,et al.  Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. , 2008, The Journal of urology.

[24]  Effects of cryoablation on short-term development of urinary fistulas in the porcine kidney. , 2003, Journal of endourology.

[25]  Boris Rubinsky,et al.  Cancer Cells Ablation with Irreversible Electroporation , 2005, Technology in cancer research & treatment.

[26]  Boris Rubinsky,et al.  Irreversible Electroporation in Medicine , 2007, Technology in cancer research & treatment.

[27]  Boris Rubinsky,et al.  Optimal parameters for the destruction of prostate cancer using irreversible electroporation. , 2008, The Journal of urology.

[28]  Li-Ming Su,et al.  Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. , 2004, The Journal of urology.

[29]  Boris Rubinsky,et al.  Irreversible Electroporation: A New Ablation Modality — Clinical Implications , 2007, Technology in cancer research & treatment.

[30]  D. Gervais,et al.  Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. , 2003, Radiology.

[31]  M. Jaroszeski,et al.  Clinical applications of electrochemotherapy. , 1999, Advanced drug delivery reviews.